## Distinguishing Class IC from Class II Antiarrhythmics ### Pharmacological Comparison **Key Point:** Class IC and Class II antiarrhythmics differ fundamentally in their mechanism of action and effects on the action potential. | Feature | Class IC (Flecainide, Propafenone) | Class II (Beta-blockers) | | --- | --- | --- | | Primary mechanism | Sodium channel blockade (very slow kinetics) | Beta-1 adrenergic receptor blockade | | Action potential duration | **Minimal/no change** | **Prolongs** (via AV node delay) | | QT interval | Minimal prolongation | Minimal change | | Phase 0 slope | Marked ↓ | Minimal effect | | AV node conduction | Slowed | **Markedly slowed** | | Heart rate | Minimal direct effect | **Decreases significantly** | | Efficacy in AF | High (converts rhythm) | Moderate (rate control only) | ### Mechanism Explanation **High-Yield:** The critical distinction lies in their opposing effects on action potential duration: 1. **Class IC Antiarrhythmics** - Extremely slow sodium channel kinetics ("ultra-slow" or "very slow" kinetics) - Profound slowing of Phase 0 depolarization - **Minimal to no effect on APD** — this is the hallmark - Produce marked QRS widening without QT prolongation - Mechanism: Reentry suppression via conduction slowing, not APD prolongation 2. **Class II Antiarrhythmics (Beta-blockers)** - Block beta-1 receptors → ↓ cAMP → ↓ calcium influx - Slow AV nodal conduction (increase AH interval) - **Prolong action potential duration** indirectly via increased vagal tone - Reduce heart rate and contractility - Mechanism: Reentry suppression via AV nodal delay and increased refractoriness ### Clinical Significance in This Patient **Clinical Pearl:** In a patient with normal LVEF and AF: - Class IC agents (flecainide, propafenone) are excellent for **rhythm control** — they convert AF to sinus rhythm in ~50–70% of cases - Class II agents (beta-blockers) are primarily for **rate control** — they slow ventricular response but do not restore sinus rhythm - The lack of APD prolongation in Class IC makes them relatively safer from torsades de pointes compared to Class IA agents **Warning:** Class IC agents are contraindicated in structural heart disease (prior MI, reduced LVEF) due to proarrhythmic risk — but this patient has normal LVEF, so Class IC is acceptable. Do not confuse this contraindication with the pharmacological difference from Class II. ### Mnemonic **IC = Minimal APD, Maximal QRS** (Sodium blockade dominates, APD unchanged) **II = Beta-block, APD prolong** (Receptor blockade + vagal enhancement) 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.